Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Cheng

Showing results (61-70 of 729) with videos related to

Pageof 73
Sort By:
Journal of Translational Medicine|May 22, 2024
TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signalingDi Zheng, Jinzhuo Ning, Hao Deng, et al.
Scientific Reports|September 9, 2024
The identification of key molecules and pathways in the crosstalk of calcium oxalate-treated TCMK-1 cells and macrophage via exosomesYushi Sun, Bojun Li, Xiangjun Zhou, et al.
The Journal of Gene Medicine|May 13, 2026
F2R Promotes Prostate Cancer Progression via COL8A1-Dependent Activation of the FAK/PI3K/AKT Signaling AxisXianfan Ding, Jinrun Wang, Jinzhuo Ning, et al.
Brain and Behavior|November 10, 2021
Relationship between PPAR-γ gene polymorphisms and ischemic stroke risk: A meta-analysisFan Cheng, Xiao-Min Si, Gong-Li Yang, et al.
International Immunopharmacology|June 8, 2023
MiR-195-5p is involved in testicular ischemia/reperfusion injury by directly targeting PELP1 and regulating spermatogonia pyroptosisKai-Xiang He, Lizhe Xu, Jin-Zhuo Ning, et al.
Chemosphere|May 24, 2022
In situ anchoring strategy to enhance dual nonradical degradation of sulfamethoxazole with high loading manganese doped carbon nitrideYouyou Hu, Siyu Sun, Jialin Guo, et al.
Functional & Integrative Genomics|March 8, 2023
MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2Bao-Feng Song, Li-Zhe Xu, Kun Jiang, et al.
Frontiers in Oncology|November 17, 2022
Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significanceDi Zheng, Jinzhuo Ning, Yuqi Xia, et al.
Current Medicinal Chemistry|May 11, 2022
Azapeptides -A History of Synthetic Milestones and Key ExamplesKai Fan Cheng, Sonya VanPatten, Mingzhu He, et al.
Frontiers in Oncology|March 3, 2020
Traditional Classification and Novel Subtyping Systems for Bladder CancerShaoming Zhu, Weimin Yu, Xiao Yang, et al.
Pageof 73

Showing results (61-70 of 729) with videos related to

Sort By:
Pageof 73
Journal of Translational Medicine|May 22, 2024
TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signalingDi Zheng, Jinzhuo Ning, Hao Deng, et al.
Scientific Reports|September 9, 2024
The identification of key molecules and pathways in the crosstalk of calcium oxalate-treated TCMK-1 cells and macrophage via exosomesYushi Sun, Bojun Li, Xiangjun Zhou, et al.
The Journal of Gene Medicine|May 13, 2026
F2R Promotes Prostate Cancer Progression via COL8A1-Dependent Activation of the FAK/PI3K/AKT Signaling AxisXianfan Ding, Jinrun Wang, Jinzhuo Ning, et al.
Brain and Behavior|November 10, 2021
Relationship between PPAR-γ gene polymorphisms and ischemic stroke risk: A meta-analysisFan Cheng, Xiao-Min Si, Gong-Li Yang, et al.
International Immunopharmacology|June 8, 2023
MiR-195-5p is involved in testicular ischemia/reperfusion injury by directly targeting PELP1 and regulating spermatogonia pyroptosisKai-Xiang He, Lizhe Xu, Jin-Zhuo Ning, et al.
Chemosphere|May 24, 2022
In situ anchoring strategy to enhance dual nonradical degradation of sulfamethoxazole with high loading manganese doped carbon nitrideYouyou Hu, Siyu Sun, Jialin Guo, et al.
Functional & Integrative Genomics|March 8, 2023
MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2Bao-Feng Song, Li-Zhe Xu, Kun Jiang, et al.
Frontiers in Oncology|November 17, 2022
Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significanceDi Zheng, Jinzhuo Ning, Yuqi Xia, et al.
Current Medicinal Chemistry|May 11, 2022
Azapeptides -A History of Synthetic Milestones and Key ExamplesKai Fan Cheng, Sonya VanPatten, Mingzhu He, et al.
Frontiers in Oncology|March 3, 2020
Traditional Classification and Novel Subtyping Systems for Bladder CancerShaoming Zhu, Weimin Yu, Xiao Yang, et al.
Pageof 73